methyl (1S)-3-t-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-8-carboxylate | 157904-28-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: methyl (1S)-3-t-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-8-carboxylate
• 英文别名: methyl (S)-3-t-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-8-carboxylate；6-O-tert-butyl 1-O-methyl (8S)-8-(chloromethyl)-4-hydroxy-2-(trifluoromethyl)-7,8-dihydro-3H-pyrrolo[3,2-e]indole-1,6-dicarboxylate
• CAS: 157904-28-4
• 化学式: C₁₉H₂₀ClF₃N₂O₅
• 分子量: 448.826
• InChiKey: HOSPPRPBRHLTEC-MRVPVSSYSA-N

物化性质

• 沸点：
  579.6±50.0 °C(predicted)
• 密度：
  1.440±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  91.9
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  methyl (1S)-3-t-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-8-carboxylate 在 盐酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 3,3'-[(Naphthalene-1,4-diyl)bis(1-oxo-2-propene-3,1-diyl)]bis[1,2,3,6-tetrahydro-1alpha-(chloromethyl)-5-hydroxy-7-(trifluoromethyl)benzo[1,2-b:4,3-b']dipyrrole-8-carboxylic acid methyl] ester
  参考文献：
  名称：

  带有3，3′-亚芳基双丙烯酰基作为接头的新型癸二环丙烷[c]吡咯并[3，2-e]吲哚双烷基化剂。

  摘要：

  我们合成了新型山高环丙烷[c]吡咯并[3,2-e]吲哚（CPI）双烷基化剂并评估了其抗肿瘤活性。在这些衍生物中，发现其中11a（AT-760）的两个Seco 3-甲氧基羰基-2-三氟甲基CPI（MCTFCPI）部分与3,3'-（1,4-亚苯基）双丙烯酰基相连。分别对HeLaS3人子宫颈癌细胞和结肠26腺癌细胞具有比8（bizelesin，U-77,779）更强的细胞毒性和抗肿瘤活性。还显示出与化合物8或丝裂霉素C（MMC）相比，化合物11a在人结肠CX-1模型中表现出改善的体内功效。发现11a的有效剂量比8a的有效剂量低2倍。

  DOI：

  10.1021/jm000107x
• 作为产物：
  描述：

  4,4,4-三氟巴豆酸甲酯 在 palladium on activated charcoal 四氯化碳 、 palladium diacetate 、 甲酸铵 、 2,4-滴二甲胺盐 、 potassium carbonate 、 三苯基膦 作用下， 以 四氢呋喃 、 甲醇 、 乙腈 为溶剂， 反应 17.5h， 生成 methyl (1S)-3-t-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-8-carboxylate
  参考文献：
  名称：

  Synthesis and antitumor activity of novel cyclopropapyrroloindole(CPI) derivatives bearing methoxycarbonyl and trifluoromethyl groups

  摘要：

  The title synthesis was achieved by employing oxidative cyclization of the enaminoester as a key step. Some of these novel 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) derivatives, dl-10c,d, (+)-10d, and (S)-21b were found to exhibit antitumor activity against murine leukemia and murine solid tumors more prominent than that of the known CPI derivatives dl-4 and the clinical trial candidates 5 and 7. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00288-6

文献信息

• Trifluoromethylpyrroloindolecarboxylic acid ester and process for
  申请人：Kyorin Pharmaceutical Co., Ltd.

  公开号：US05629430A1

  公开（公告）日：1997-05-13

  Trifluoromethylpyrroloindolecarboxylic acid ester derivatives, and optical isomers and pharmaceutically acceptable salts thereof are provided which are represented by the general formula (1): ##STR1## or the general formula (2): ##STR2## The compounds are antineoplastic agents which are selective to cancer cells, effective also to solid cancer, and less toxic.

  提供了三氟甲基吡咯吲哌酮酸酯衍生物，以及它们的光学异构体和药学上可接受的盐，其通式表示为（1）： ##STR1## 或通式（2）： ##STR2## 这些化合物是选择性作用于癌细胞的抗肿瘤剂，对实体癌也有效，并且毒性较小。
• Novel Cyclopropapyrroloindole Derivative (AT-3510) Bearing Methoxycarbonyl and Trifluoromethyl Groups
  作者：Yasumichi Fukuda、Hirosuke Furuta、Yoshie Kusama、Hiroyuki Ebisu、Yasuo Oomori、Shiro Terashima

  DOI：10.1021/jm980668c

  日期：1999.4.22

  The seco-Cl 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) derivatives dl- and/or (S)-10 carrying various acyl moieties at the NG-position were synthesized along with their prodrugs (S)-12, and their antitumor activity was evaluated. Among these derivatives, AT-3510 [(S)-12m], the novel prodrug MCTFCPI derivative carrying a 5-(7-methoxybenzofuran-2-ylcarbonyl)aminoindole-2-carbonyl group at the NG-position, was found to exhibit more excellent antitumor activity against human tumor xenografts than the clinical trial candidates carzelesin (6) and KW-2189 (7) and cisplatin.
• The novel cyclopropapyrroloindole(CPI) bisalkylators bearing 3,3′-(1,4-phenylene)diacryloyl group as a linker
  作者：Yasumichi Fukuda、Shigeki Seto、Hirosuke Furuta、Hiroyuki Ebisu、Yasuo Oomori、Shiro Terashima

  DOI：10.1016/s0960-894x(98)00346-1

  日期：1998.8

  The novel cyclopropapyrroloindole(CPI) bisalkylators were synthesized and their antitumor activity was evaluated. Among these derivatives, AT-760 (5a) in which the two 3-methoxycarbonyl-2-trifluoromethylCPI (MCTFCPI) moieties are connected with a 3,3'-(1,4-phenylene)diacryloyl group, was found to exhibit more prominent cytotoxicity and antitumor activity than U-77,779 (bizelesin) (1). (C) 1998 Elsevier Science Ltd. All rights reserved.
• The novel cyclopropapyrroloindole(CPI) bisalkylators bearing methoxycarbonyl and trifluoromethyl groups
  作者：Yasumichi Fukuda、Hirosuke Furuta、Yoshie Kusama、Hiroyuki Ebisu、Yasuo Oomori、Shiro Terashima

  DOI：10.1016/s0960-894x(98)00235-2

  日期：1998.6

  The novel 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) bisalkylators were synthesized and their antitumor activity was evaluated. Among these derivatives, 7f in which two MCTFCPI moieties are connected with a 5,5'-bis(2-carbonyl-1 H-indole) group, was found to exhibit more prominent cytotoxicity and antitumor activity than U-77,779 (bizelesin) (2). (C) 1998 Elsevier Science Ltd. All rights reserved.
• Novel Seco Cyclopropa[<i>c</i>]pyrrolo[3,2-<i>e</i>]indole Bisalkylators Bearing a 3,3‘-Arylenebisacryloyl Group as a Linker
  作者：Yasumichi Fukuda、Shigeki Seto、Hirosuke Furuta、Hiroyuki Ebisu、Yasuo Oomori、Shiro Terashima

  DOI：10.1021/jm000107x

  日期：2001.4.1

  We synthesized the novel seco cyclopropa[c]pyrrolo[3,2-e]indole (CPI) bisalkylators and evaluated their antitumor activity. Among these derivatives, 11a (AT-760), in which the two seco 3-methoxycarbonyl-2-trifluoromethyl CPI (MCTFCPI) moieties are connected with a 3,3'-(1,4-phenylene)bisacryloyl group, was found to exhibit more potent cytotoxicity and antitumor activity against HeLaS3 human uterine

  我们合成了新型山高环丙烷[c]吡咯并[3,2-e]吲哚（CPI）双烷基化剂并评估了其抗肿瘤活性。在这些衍生物中，发现其中11a（AT-760）的两个Seco 3-甲氧基羰基-2-三氟甲基CPI（MCTFCPI）部分与3,3'-（1,4-亚苯基）双丙烯酰基相连。分别对HeLaS3人子宫颈癌细胞和结肠26腺癌细胞具有比8（bizelesin，U-77,779）更强的细胞毒性和抗肿瘤活性。还显示出与化合物8或丝裂霉素C（MMC）相比，化合物11a在人结肠CX-1模型中表现出改善的体内功效。发现11a的有效剂量比8a的有效剂量低2倍。